# NUVAXOVID - **Website:** - **Primary alias:** `nuvaxovid.com` ## Description NUVAXOVID is a protein-based, non-mRNA COVID-19 vaccine presented by Sanofi for eligible people in the United States. It is indicated to help protect adults aged 65 and older, as well as people aged 12 through 64 who are at high risk for severe COVID-19. The vaccine does not contain SARS-CoV-2 and cannot cause COVID-19, although vaccination may not protect everyone. Information on the brand’s website describes clinical-trial results, including reported protection against COVID-19 illness and moderate-to-severe disease, and notes that most side effects in trials were mild to moderate and did not prevent daily activities, according to FDA grading. NUVAXOVID may be given at the same time as a flu shot, and people may be eligible regardless of which COVID-19 vaccine they received in previous seasons. The website offers efficacy and safety information, frequently asked questions, prescribing information, and a vaccine locator, and encourages patients to discuss the vaccine with a doctor or pharmacist. It also explains important risks, including allergic reactions and rare cases of myocarditis or pericarditis. ## Industries - ⛑ Health - ⛑ Biotechnology and Pharmaceuticals _(under Health)_ ## Colors | Name | Hex | Theme | | --- | --- | --- | | Electric Violet | #7a00e6 | accent | | Mine Shaft | #212121 | dark | | White | #ffffff | light | ## Fonts - Poppins — asset _(google)_ - Poppins — asset _(google)_ --- _Source: _ _See [/llms.txt](/llms.txt) for a full list of agent-readable pages, and [/auth.md](/auth.md) for how agents authenticate._